LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
+7.65%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$32.3M
Cap. Flow
% of AUM
3.43%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,946
New
150
Increased
990
Reduced
857
Closed
216
Top Buys
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.38M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.91M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$2.69M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$2.33M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$7.18M |
| 2 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$4.57M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$853K |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$627K |
| 5 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
Sector Composition
| 1 | Financials | 16.18% |
| 2 | Technology | 15.31% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
CarGurus
CARG
$3.58B
| $10.2K | ﹤0.01% |
452
-13
| -3% | -$294 |
|
1452
BioMarin Pharmaceuticals
BMRN
$10.4B
| $10.2K | ﹤0.01% |
118
+1
| +0.9% | +$87 |
|
1453
Ultrapar
UGP
$4.1B
| $10.2K | ﹤0.01% |
2,602
+1,164
| +81% | +$4.58K |
|
1454
Kornit Digital
KRNT
$647M
| $10.2K | ﹤0.01% |
348
+224
| +181% | +$6.58K |
|
1455
Pentair
PNR
$18.2B
| $10.2K | ﹤0.01% |
158
| – | – |
|
1456
Allete
ALE
$3.67B
| $10.2K | ﹤0.01% |
176
-9
| -5% | -$522 |
|
1457
Columbia Sportswear
COLM
$2.99B
| $10.2K | ﹤0.01% |
132
-36
| -21% | -$2.78K |
|
1458
Ultragenyx Pharmaceutical
RARE
$2.92B
| $10.1K | ﹤0.01% |
220
+28
| +15% | +$1.29K |
|
1459
Unitil
UTL
$827M
| $10.1K | ﹤0.01% |
200
+12
| +6% | +$609 |
|
1460
First Mid Bancshares
FMBH
$945M
| $10.1K | ﹤0.01% |
419
-931
| -69% | -$22.5K |
|
1461
Primerica
PRI
$8.88B
| $10.1K | ﹤0.01% |
51
-1
| -2% | -$198 |
|
1462
Insmed
INSM
$30.8B
| $10.1K | ﹤0.01% |
477
+160
| +50% | +$3.38K |
|
1463
Nu Skin
NUS
$596M
| $10.1K | ﹤0.01% |
303
-17
| -5% | -$564 |
|
1464
Cytokinetics
CYTK
$6.12B
| $10K | ﹤0.01% |
308
+50
| +19% | +$1.63K |
|
|
CMRC
1465
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $10K | ﹤0.01% |
1,007
+671
| +200% | +$6.68K |
|
1466
Sleep Number
SNBR
$214M
| $10K | ﹤0.01% |
367
+85
| +30% | +$2.32K |
|
1467
Saic
SAIC
$4.9B
| $10K | ﹤0.01% |
89
+3
| +3% | +$337 |
|
1468
Diodes
DIOD
$2.44B
| $9.99K | ﹤0.01% |
108
-18
| -14% | -$1.67K |
|
|
AAMI
1469
Acadian Asset Management Inc.
AAMI
$1.74B
| $9.97K | ﹤0.01% |
476
| – | – |
|
1470
Medifast
MED
$154M
| $9.95K | ﹤0.01% |
108
+90
| +500% | +$8.29K |
|
1471
TransAlta
TAC
$3.75B
| $9.93K | ﹤0.01% |
1,061
| – | – |
|
1472
Lumentum
LITE
$11.4B
| $9.93K | ﹤0.01% |
175
+69
| +65% | +$3.91K |
|
1473
iShares 7-10 Year Treasury Bond ETF
IEF
$36.1B
| $9.88K | ﹤0.01% |
102
| – | – |
|
|
QVCGA
1474
QVC Group, Inc. Series A Common Stock
QVCGA
$92M
| $9.87K | ﹤0.01% |
199
-1
| -0.5% | -$50 |
|
1475
Puma Biotechnology
PBYI
$225M
| $9.86K | ﹤0.01% |
2,793
| – | – |
|